Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Antje Prasse, Carlo Bertucci et al.|Journal of Medicinal Chemistry|2021Cited by 55
Telomerase-based Cancer Therapeutics: A Review on their Clinical TrialsNicola Relitti, Giuseppe Campiani, A. Prasanth Saraswati et al.|Current Topics in Medicinal Chemistry|2020Cited by 54
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological EvaluationA. Prasanth Saraswati, Giuseppe Campiani, Nicola Relitti et al.|ACS Medicinal Chemistry Letters|2020Cited by 44
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, Giuseppe Campiani, A. Prasanth Saraswati et al.|European Journal of Medicinal Chemistry|2020Cited by 43
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitorsA. Prasanth Saraswati, Giuseppe Campiani, Nicola Relitti et al.|Drug Discovery Today|2019Cited by 34